{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-003387","form_type":"8-K","ticker":"TWST","cik":"0001581280","company_name":"Twist Bioscience Corp","filed_at":"2025-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.068063+00:00","generated_at":"2026-05-27T03:58:44.879754+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Twist Bioscience Q1 FY2025 revenue $88.7M (+24% YoY), gross margin 48.3%, net loss narrows to $31.6M","bullets":["Total revenue $88.7M vs $71.5M YoY; SynBio +28% to $34.4M, NGS +23% to $48.6M.","Gross margin improved 7.8 points to 48.3% from 40.5% in prior year period.","Net loss per share ($0.53) vs ($0.75) YoY; adjusted EBITDA ($16.3M) vs ($27.8M).","FY2025 revenue guidance $372M-$379M; expects gross margin over 50% in Q4 FY2025.","Cash and short-term investments $270.8M at Dec 31, 2024; shipped to ~2,376 customers."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-003387","json":"https://secwatch.observer/filing/0001628280-25-003387.json","markdown":"https://secwatch.observer/filing/0001628280-25-003387.md","text":"https://secwatch.observer/filing/0001628280-25-003387.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1581280/000162828025003387/0001628280-25-003387-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1581280/000162828025003387/twist-20250203.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:58:44.879754+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}